# Novum Pharma, LLC – FDA Inspection, Sep 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/novum-pharma-llc/e7687eb8-6d1e-48e7-adbe-92ee0bead8a5
Source feed: FDA_Inspections

> FDA inspection 1102732 of Novum Pharma, LLC, September 24, 2019. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR parts 211 and 310. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102732
- Company Name: Novum Pharma, LLC
- Inspection Date: 2019-09-24
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Officers

- [Investigator](https://www.keypedia.com/people/alan-m-roberts/b6565c30-6228-4f51-a1b7-369bffe54e9c)
- [Company Rep](https://www.keypedia.com/people/nicholas-p-diorio/fba94f6f-38b9-4d30-b8a1-d6c9d4769e49)

Company: https://www.keypedia.com/companies/novum-pharma-llc/47853251-3b42-4d95-8efb-61c8464c1150

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c